Saamya Biotech (India) Limited reported unaudited earnings results for the second quarter and six months ended September 30, 2015. For the quarter, the company reported net sales/income from operations (net of excise duty) of INR 76,707,236 against INR 0 a year ago. Profit from operations from other income, interest and exceptional items was INR 2,756,612 against INR 861,413 a year ago. Loss from ordinary activities before and after tax was INR 1,782,474 against INR 871,656 a year ago. Net loss for the period was INR 1,782,474 against INR 881,656 a year ago. Basic and diluted earnings per share were INR 0.07 against INR of 0.04 a year ago.

For the six months, the company reported net sales/income from operations (net of excise duty) of INR 144,021,942 against INR 0 a year ago. Profit from operations from other income, interest and exceptional items was INR 5,148,266 against INR 1,763,700 a year ago. Loss from ordinary activities before and after tax was INR 4,190,674 against INR 1,830,962 a year ago. Net loss for the period was INR 4,190,674 against INR 1,830,962 a year ago. Basic and diluted earnings per share were INR 0.17 against INR of 0.07 a year ago.